Skip to content

Partial-thickness/Non-advanced vs. Full-thickness/MCAT Tunnelling for the Treatment of Multiple Gingival Recessions

Partial-thickness/Non-advanced vs. Full-thickness/MCAT Tunnelling for the Treatment of Multiple Gingival Recessions: a Multi-centre Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05655247
Acronym
Tun_RCT
Enrollment
34
Registered
2022-12-19
Start date
2023-01-05
Completion date
2027-12-30
Last updated
2023-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Brief summary

Included patients will be randomly allocated to the test (split-thickness non-advanced tunnel - Zabalegui et al. 1999) or to the control group (full-thickness coronally-advanced tunnel - MCAT - Aroca et al. 2010).

Detailed description

Design: Randomized, clinical, outcome-assessor blinded, multi-centric, superiority trial with two parallel groups and a 1:1 allocation ratio. The follow-up of individual patients will be 6 months (to be extended to 3/5 years if funding will be available) Patients with a minimum of two-adjacent teeth with RT1 and/or RT2 gingival recessions (at least one with a depth \>2 mm) with indication for root coverage treatment will be included. RT2 gingival recessions will be considered not eligible when associated with interproximal exposure of the CEJ. Mean root coverage (linear) at 6-months will be evaluated as the primary outcome by a blinded outcome assessor.

Interventions

PROCEDURESplit-thickness non-advanced tunnel (Zabalegui et al. 1999)

A split-thickness non-advanced tunnel will be performed according to Zabalegui et al. (1999).

PROCEDUREFull-thickness coronally-advanced tunnel (Aroca et al. 2010)

A full-thickness coronally-advanced tunnel (Modified Coronally Advanced Tunnel - MCAT) will be performed according to Aroca et al. (2010).

Sponsors

Osteology Foundation
CollaboratorOTHER
Universidad Complutense de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Any patient having a minimum of two adjacent teeth with RT1 and/or RT2 gingival recessions (at least one with a depth \>2 mm) with indication for root coverage treatment, being at least 18 years old and able and agreeing to sign a written informed consent form will be potentially eligible for this trial. RT2 gingival recessions will be considered not eligible when associated with interproximal exposure of the CEJ (interdental gingival recession). In case of multiple RT1/RT2 recessions involving 2 or 3 teeth, at least 2 or 1 more non-included adjacent teeth should respectively be present in order to guarantee a minimum of 4 adjacent teeth (including the included ones) in the region of interest (ROI) for digital scanning. Patients fitting to all the inclusion criteria as above will be not included in the study if they appear to be unable to attend to the study-related procedures (including the follow-up visits) or if one or more of the following systemic or local

Exclusion criteria

are found in the enrollment phase. Systemic primary

Design outcomes

Primary

MeasureTime frameDescription
Mean Root Coverage (MRC) (6 months)6 months after surgeryDefined as the percentage of root coverage in the mid-buccal aspect obtained with respect to baseline. The MRC will be measured as a percentage (% mm, with probe) 6 months after surgery. Considering the study will also include RT2 gingival recessions (we expect CRC not possible in some cases), the linear 6 months MRC will be evaluated as the primary outcome of the study.

Secondary

MeasureTime frameDescription
Complete Root Coverage (CRC)3 and 6 months after surgeryDefined as the presence/absence of complete root coverage in the mid-buccal aspect. It will be measured at 3- and 6-months after surgery and evaluated as linear mid-buccal measurement (mm, with probe).
Recession Reduction (RR)3 and 6 months after surgeryDefined as the reduction in recession in the mid-buccal aspect with respect to baseline. It will be calculated at 3- and 6-months after surgery and evaluated as linear mid-buccal measurement (mm, with probe).
Contact-point/Papilla-tip (DCP) distance changes3 and 6 months after surgeryDefined as the change in the linear distance between the contact point and the top of papilla at the mesial aspect of each tooth (Aroca et al. 2010) with respect to baseline. It will be measured at 3- and 6-months after surgery and evaluated as linear measurement (mm, with probe).
Keratinized Tissue Height (KTH) changes3 and 6 months after surgeryDefined as the linear changes in mid-buccal keratinized tissue height (distance from the gingival margin and the mucogingival junction) with respect to baseline. It will be calculated at 3- and 6-months after surgery and evaluated as linear mid-buccal measurement (mm, with probe).
Probing Pocket Depth (PPD) changes3 and 6 months after surgeryDefined as the changes in PPD (distance from the gingival margin to the bottom of the probeable sulcus) with respect to baseline. It will be calculated at 3- and 6-months after surgery and evaluated only as linear mid-buccal measurement (mm, with probe).
Clinical Attachment Level (CAL) changes3 and 6 months after surgeryDefined as the changes in CAL (distance from the CEJ to the bottom of the probeable sulcus) with respect to baseline. It will be calculated at 3- and 6-months after surgery and evaluated only as linear mid-buccal measurement (mm, with probe).
Dental hypersensitivity (DH)3 and 6 months after surgeryAssessed by 10 s air spray applied to the buccal cervical area. It will be evaluated at baseline and at 3- and 6-months after surgery.
Root-coverage Esthetic Score (RES)3 and 6 months after surgeryEvaluated at 3- and 6-months according to Cairo et al. (2009).
Digital Mean Root Coverage (dMRC)3 and 6 months after surgeryDefined as the percentage of root surface coverage obtained with respect to baseline. The sMRC will be measured at 3- and 6-months after surgery. It will be assessed as buccal surface measurement (% mm2, digital assessment).
Digital Complete Root Coverage (dCRC)3 and 6 months after surgeryDefined as the presence/absence of complete root surface coverage. It will be measured at 3- and 6-months after surgery and evaluated as buccal surface measurement (mm2, digital assessment).
Digital Recession Reduction (dRR)3 and 6 months after surgeryDefined as the reduction in recession surface with respect to baseline. It will be calculated at 3- and 6-months after surgery and evaluated as buccal surface measurement (mm2, digital assessment).
Digital Contact-point/Papilla-tip (dDCP) distance changes3 and 6 months after surgeryDefined as the changes in the area between the contact point and the top of papilla at the mesial aspect of each tooth with respect to baseline. It will be measured at 3- and 6-months after surgery and evaluated as area measurement (mm2, digital assessment).
Digital Gingival thickness (dGT)3 and 6 months after surgeryIt will be measured both at the gingival margin and 1-mm apically. It will be assessed as a mid-buccal thickness measurement (mm, digital assessment) at 3- and 6-months after surgery.
Digital Keratinized Tissue Height (dKTH) changes3 and 6 months after surgeryDefined as the changes in keratinized tissue surface (surface delimited apico-coronally by the gingival margin and the mucogingival junction and mesio-distally by the projection of a line passing by the contact-point and perpendicular to the occlusal aspect of each tooth) with respect to baseline. It will be calculated at 3- and 6-months after surgery and evaluated as buccal surface measurement (mm2, digital assessment).
Mean Root Coverage (MRC) (3 months)3 months after surgeryDefined as the percentage of root coverage in the mid-buccal aspect obtained with respect to baseline. The MRC will be measured as a percentage (% mm, with probe) 3 months after surgery.

Other

MeasureTime frameDescription
PROMs - Number of analgesic tablets14 days after surgeryThe patient will document in the evening, preferably at the same time, the number of ibuprofen tablets taken each day from day-0 to day-7 and at day-14 post-surgery.
PROMs - SwellingJust after surgery, 12 hours and 1, 2, 3, 4, 5, 6, 7, 14 days after surgeryThe patient will self-report on a 100-mm VAS scale ranging from 0 (no swelling whatsoever) to 100 (worst swelling imaginable) the perceived swelling. The swelling will be reported just after surgery, 12 hours post-operatively and 1, 2, 3, 4, 5, 6, 7, 14 days post-operatively in the evening, preferably at the same time.
PROMs - BleedingJust after surgery, 12 hours and 1, 2, 3, 4, 5, 6, 7, 14 days after surgeryThe patient will self-report on a 100-mm VAS scale ranging from 0 (no bleeding whatsoever) to 100 (continuous copious bleeding) the perceived bleeding. The bleeding will be reported just after surgery, 12 hours post-operatively and 1, 2, 3, 4, 5, 6, 7, 14 days post-operatively in the evening, preferably at the same time.
PROMs - Discomfort during surgeryJust after surgeryThe patient will answer on a 100-mm VAS scale just after the surgery to the following question: How did you perceive the procedure? (Burkhardt et al. 2015). The VAS scale will range from 0 (no problem whatsoever) to 100 (unbearable).
PROMs - Aesthetic consequences (self-evaluation)6 months after surgeryThe patient will self-report on a 100-mm VAS scale ranging from 0 (terrible) to 100 (perfect) the perceived aesthetic of the included zone. The aesthetic self-evaluation will be completed 6 months post-surgery.
PROMs - Satisfaction (self-evaluation)6 months after surgeryThe patient will self-report on a 100-mm VAS scale ranging from 0 (terrible) to 100 (perfect) the overall satisfaction for the treatment of the included zone. The satisfaction self-evaluation will be completed at 6-months post-surgery.
PROMs - Oral Health Impact Profile-14 (OHIP-14)1, 2, 3, 4, 5, 6, 7, 14 days, as well as 6 months, after surgeryThe OHIP-14 questionnaire will be evaluated at 1, 2, 3, 4, 5, 6, 7, 14 days and 6 months post-surgery.
PROMs - Patient concerns with gingival recession6 months after surgeryPatient concerns with gingival recession will be assessed with a condition-specific health-related quality-of-life instrument (Tonetti et al. 2018) assessing the level of concern in terms of aesthetics, sensitivity to cold, sensitivity to brushing, root/tooth wear, development of cavity and fear to lose the involved teeth using a questionnaire on a 5-point Likert scale at 6 months.
Duration of surgeryDuring surgeryThe time in minutes of the net (excluding time used for photographs or other non-surgery related things) duration of the surgery in the recipient site (after palate suture), from the first incision to the completion of the last suture (the composite stops placement in the control group will be considered within the duration of surgery).
Early Wound Healing1 and 2 weeks after surgeryIt will be evaluated by the outcome assessor on a 100-mm VAS scale ranging from 0 (very bad) to 100 (very good). The early wound healing will be evaluated at 1 and 2 weeks post-surgery.
Micro-vascularization (eco-doppler)Just after surgery; 1, 2, 4 weeks after surgery; 3 and 6 months after surgeryIt will be evaluated on patients treated in one of the centers, using a 3D printed stent, just after surgery, and at 1-, 2- and 4-week, as well as 3- and 6-months examinations, after-surgery.
PROMs - Time to non-significant pain14 days after surgeryIt will be defined as the time (days) to reach a pain VAS\<10.
PROMs - PainJust after surgery, 12 hours and 1, 2, 3, 4, 5, 6, 7, 14 days after surgeryThe patient will self-report on a 100-mm VAS scale ranging from 0 (no pain whatsoever) to 100 (worst pain imaginable) the perceived pain. The pain will be reported just after surgery, 12 hours post-operatively and 1, 2, 3, 4, 5, 6, 7, 14 days post-operatively in the evening, preferably at the same time.

Countries

Italy

Contacts

Primary ContactMario Romandini
mario.romandini@gmail.com+393801563046

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026